The clinical case for combining AOD-9604 with GLP-1 therapy in patients who have plateaued is mechanistically coherent (the two compounds act on different sides of the energy balance equation through non-overlapping mechanisms) and is not supported by randomized controlled trial evidence for the specific combination
P.GadianoA
Similar to the beginning stage, the symptoms may affect the patients awareness, senses and emotions, as well as physical movement: Confusion or forgetfulness Out of body sensations Blurred vision Ongoing fear or anxiety Inability to speak or move Tremors, muscle tension, repetitive uncontrollable movements Stiff jaw and clenched teeth End Symptoms The end of a seizure triggers the postictal phase, the recovery period
A specific example: a patient starting at a low compounded semaglutide dose for 4 weeks, escalating to 0.5 mg, then 1.0 mg, and beyond, will see monthly costs land near $200 in low-dose phase and $250 to $300 at higher maintenance doses
OB: Writing review and editing, Investigation, Methodology